文献速递眼底病与葡萄膜炎

年龄相关性黄斑变性中未治疗的非渗出性黄斑新生血管的渗出性进展:系统评价与Meta分析

Exudative Progression of Treatment-Naïve Nonexudative Macular Neovascularization in Age-Related Macular Degeneration: A Systematic Review With Meta-Analyses.
PubMed 文献 · Am J Ophthalmol · 2023-09-01

该系统评价与Meta分析检索10个文献数据库至2023年3月26日,纳入16项研究共384只未经治疗的非渗出性黄斑新生血管眼,1年渗出性进展率为20.9%(95%CI 13.1%-29.8%),2年为30.7%(95%CI 21.8%-40.4%),个体参与者Meta分析结果相似。识别这些病变可能有助于制定更好的个体化随访方案,更密切的监测可能有助于更早诊断渗出性进展。

要点

  • 未经治疗的非渗出性黄斑新生血管眼1年渗出性进展率为20.9%(95%CI 13.1%-29.8%)。
  • 未经治疗的非渗出性黄斑新生血管眼2年渗出性进展率为30.7%(95%CI 21.8%-40.4%)。
  • 快速渗出性进展的危险因素包括视网膜下脂质小球、大MNV面积、快速MNV生长等。

核心结论

  • AMD中的非渗出性MNV具有高渗出性进展风险。
  • 识别这些病变可能有助于制定更好的个体化随访方案,更密切的监测可能有助于更早诊断渗出性进展。

研究设计与样本

  • 系统评价与患病率Meta分析及个体参与者Meta分析,检索10个文献数据库(2023年3月26日),纳入16项研究共384只未经治疗的非渗出性MNV眼。

主要发现

  • 渗出性进展在1年时为20.9%(95%CI 13.1%-29.8%),2年时为30.7%(95%CI 21.8%-40.4%)。
  • 个体参与者Meta分析显示1年渗出性进展为18.9%(95%CI 13.5%-26.3%),2年为31.3%(95%CI 24.2%-40.0%)。
  • 快速渗出性进展的危险因素包括视网膜下脂质小球、大MNV面积、快速MNV生长、色素上皮脱离高度和宽度的增长、分支模式的出现以及MNV周围低反射晕的发展。

临床怎么用

  • 识别非渗出性MNV病变可能有助于制定更好的个体化随访方案,更密切的监测可能有助于更早诊断渗出性进展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To systematically review and report the rate of exudative progression over time in patients with nonexudative macular neovascularization (MNV) in age-related macular degeneration (AMD). DESIGN: Systematic review with prevalence meta-analyses and individual participant meta-analysis. METHODS: We searched 10 literature databases on March 26, 2023, for studies of consecutive patients with treatment-naïve nonexudative MNV in AMD. The primary outcome of interest was time from diagnosis to exudative progression. We conducted meta-analyses on the prevalence of exudative progression at 1 and 2 years. Where possible, we extracted individual participant data from studies and conducted an individual participant meta-analysis and explored the exudative progression using a time-to-event curve. RESULTS: We identified 16 eligible studies with a total of 384 eyes with nonexudative MNV. Exudative progression had occurred in 20.9% (95% CI 13.1%-29.8%) of eyes at 1 year and in 30.7% (95% CI 21.8%-40.4%) at 2 years. Similar results were observed in the individual participant meta-analysis, showing exudative progression in 18.9% (95% CI 13.5%-26.3%) of eyes at 1 year and 31.3% (95% CI 24.2%-40.0%) at 2 years. Risk factors for a fast exudative progression were the presence of subretinal lipid globules, large MNV areas, rapid MNV growth, growth in pigment epithelium detachment height and width, appearance of a branching pattern, and development of a hyporeflective halo around the MNV. CONCLUSIONS: Nonexudative MNVs in AMD are at high risk of exudative progression. Recognition of these lesions may allow for better individualized follow-up regimens in which closer monitoring may facilitate earlier diagnosis of exudative progression.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Nissen AHK, Kiilgaard HC, van Dijk EHC, et al. Exudative Progression of Treatment-Naïve Nonexudative Macular Neovascularization in Age-Related Macular Degeneration: A Systematic Review With Meta-Analyses. Am J Ophthalmol. 2023. PMID: 37659600. doi:10.1016/j.ajo.2023.08.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。